Auris Medical Holding Ltd (EARS)

0.79 -0.02  -2.63% NASDAQ Oct 30, 16:58 USD

Auris Medical Research and Development Expense (Quarterly)

View 4,000+ financial data types
Browse...
View Full Chart

Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 2013. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2018 0.0351M
Sept. 30, 2018 1.725M
June 30, 2018 2.045M
March 31, 2018 3.103M
Dec. 31, 2017 4.339M
Sept. 30, 2017 4.386M
June 30, 2017 4.794M
March 31, 2017 5.956M
Dec. 31, 2016 5.010M
Sept. 30, 2016 6.503M
June 30, 2016 7.496M
March 31, 2016 6.180M
   
Dec. 31, 2015 5.721M
Sept. 30, 2015 6.099M
June 30, 2015 9.286M
March 31, 2015 6.543M
Dec. 31, 2014 4.840M
Sept. 30, 2014 5.125M
June 30, 2014 4.725M
March 31, 2014 4.646M
Dec. 31, 2013 3.240M
Sept. 30, 2013 4.234M
June 30, 2013 4.68M
March 31, 2013 2.121M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

R&D Expense Definition

R&D expenses are a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Benchmarks

Kiniksa Pharmaceuticals Ltd 22.32M
Cyclerion Therapeutics Inc 13.79M
OncoCyte Corp 3.225M

Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 0.0351M Dec 2018
Maximum 7.496M Jun 2016
Average 4.407M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.